Left ventricular remodelling index (LVRI) in various pathophysiological conditions: A real-time three-dimensional echocardiographic study

Heart

Volumn 93, Issue 2, 2007, Pages 205-209

  De Castro, Stefano ^a   Caselli, Stefano ^a   Maron, Martin ^b   Pelliccia, Antonio ^c   Cavarretta, Elena ^a   Maddukuri, Prasad ^b   Cartoni, Domenico ^a   Di Angelantonio, Emanuele ^a   Kuvin, Jeffrey T ^b   Patel, Ayan R ^b   Pandian, Natesa G ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b TUFTS UNIVERSITY   (United States)

^c Institute of Sports Science   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; OBSERVER VARIATION; PRIORITY JOURNAL; THREE DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; ANALYSIS OF VARIANCE; CARDIAC VOLUME; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; FEMALE; HEART VENTRICLES; HUMANS; MALE; OBSERVER VARIATION; SPORTS; VENTRICULAR REMODELING;

EID: 33846615543     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.093997     Document Type: Article

References (48)

1. Cohn JN, Ferrari R, Sharpe N. Cardiac remodelling, concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 2000;35:5 69-82.
2. Opie L. Heart physiology. Philadelphia, PA: Lippincott Williams and Wilkins, 2004.
3. Spirito P, Pelliccia A, Proschan MA, et al. Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol 1994;74(8):802-6.
4. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance. Heart 2005;91(11):1380-2.
5. Maron BJ, Casey SA, Hurrell DG, et al. Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. Am J Cardiol 2003;91(10):1195-8.
6. Pfeffer MA, Braunwald E. Ventricular remodeling alter myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-72.
7. Hein S, Amon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart. Structural deterioration and compensatory mechanisms. Circulation 2003;107:984-91.
8. Eichhorn P, Grimm J, Koch R, et al. Left ventricular relaxation in patients with left ventricular hypertrophy secondary to aortic valve disease. Circulation 1982;65:1395-404.
9. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19(7):1559-60.
10. Pouleur HG, Konstam MA, Udelson JE, et al. Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD investigators. J Am Coll Cardiol 1993;22(4A):43A-48A.
11. Doughty RN, Whalley GA, Walsh HA, et al. CAPRICORN Echo Substudy Investigators. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy, Circulation 2004;109(2):201-6.
12. Van Royen N, Jaffe CC, Krumholz HM, et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol 1996;77:843-50.
13. Konstam MA, Kronenberg MW, Rousseau MF, et al. Effects of the angiotensin converting enzyme inhibitor enolapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation 1993;88:2277-83.
14. Anand IS, Florea VG, Solomon SD, et al. Noninvasive assessment of left ventricular remodeling: concepts, techniques, and implications for clinical trials [review]. J Card Fail 2002;8(6 Suppl):S452-64.
15. Gutierrez-Chico JL, Zamorano JL, Perez de Isla L, et al. Comparison of left ventricular volumes and ejection fractions measured by three-dimensional echocardiography versus by two-dimensional echocardiography and cardiac magnetic resonance in patients with various cardiomyopathies. Am J Cardiol 2005;95(6):809-13.
16. Jenkins C, Bricknell K, Hanekom L, et al. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol 2004;44(4):878-86.
17. Monaghan MJ. Role of real time 3D echocardiography in evaluating the left ventricle. Heart 2006;92(1):131 -6.
18. Kuhl HP, Schreckenberg M, Rulands D, et al. High-resolution transthoracic real-time three-dimensional echocardioaraphy: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004;43(11):2083-90.
19. Fleming SM, Cumberledge B, Kiesewetter C, et al. Usefulness of real-time three-dimensional echocardiography for reliable measurement of cardiac output in patients with ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2005;95(2):308-10.
20. Maron BJ, Douglas PS, Graham TP, et al. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Cardiol 2005;45(8):1322-6.
21. Maron BJ, Ackerman MJ, Nishimura RA, et al. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol 2005;45:1340-5.
22. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Eng J Med 1998;339:364-9.
23. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
24. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-1708.
25. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979;43:1242-4.
26. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995;25:879-84.
27. Ghali JK, Youlian L, Cooper RS. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 1998;31:1635-40.
28. Bonow RO, Lakatos E, Maron BJ, et al. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991;84:1625-35.
29. Douglas PS, Morrow R, Ioli A, et al. Left ventricular shape, afterload, and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989;13:311-15.
30. Vasan RS, Larson MG, Benjamin EJ, et al. Left ventricular dilation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997;336:1350-5.
31. De Simone G, Di Lorenzo LD, Moccia D, et al. Hemodynamic hypertrophied ventricular patterns in systemic hypertension. Am J Cardiol 1987;60:1317-21.
32. Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary artery disease in an elderly cohort: the Framingham study. Ann Intern Med 1989;110:101-8.
33. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
34. Ghali JK, Liao Y, Simmons B, et al. The prognostic role of left ventricular hypertrophy in patients with and without coronary artery disease. Ann Intern Med 1992;117:831-6.
35. Myerson SG, Montgomery HE, World MJ, et al. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension 2002;40(5):673-8.
36. Van den Bosch AE, Robbers-Visser D, Krenning BJ, et al. Comparison of real-time three-dimensional echocardiography to magnetic resonance imaging for assessment of left ventricular mass. Am J Cardiol 2006;97(1):113-7.
37. Mor-Avi V, Sugeng L, Weinert L, et al. Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging. Circulation 2004;110(13):1814-8.
38. Oe H, Hozumi T, Arai K, et al. Comparison of accurate measurement of left ventricular mass in patients with hypertrophied hearts by real-time three-dimensional echocardiography versus magnetic resonance imaging. Am J Cardiol 2005;95(10):1263-7.
39. De Castro S, Pelliccia A, Caselli S, et al. Remodeling of left ventricle in athlete's heart: a three dimensional echocardiographic and magnetic resonance imaging study. Heart 2006;92:975-6.
40. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830-7.
41. Ramanathan KB, Knowles J, Connor MJ, et al. Natural history of chronic mitral insufficiency: relation of peak systolic pressure/end- systolic volume ratio to morbidity and mortality. J Am Coll Cardiol 1984;3:1412-6.
42. Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335:1417-23.
43. Bonow RO, Rosing DR, McIntosh CL, et al. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function. Circulation 1983;68:509-17.
44. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
45. St John Sutton M, Pfeffer MA, Plappert T, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994;89(1):68-75.
46. Mannaerts HF, van der Heide JA, Kamp O, et al. Early identification of left ventricular remodelling after myocardial infarction, assessed by transthoracic 3D echocardiography. Eur Heart J 2004;25:680-7.
47. Bottini PB, Carr AA, Prisant LM, et al. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 1995;8:221-8.
48. Gopal AS, Shen Z, Sapin PM, et al. Assessment of cardiac function by three-dimensional echocardiography compared with conventional noninvasive methods. Circulation 1995;92:842-53.